OUR CURRENT CLINICAL TRIALS
SIBO STUDY
We are studying the effects of two dosing regimens of a new non-absorbable antibiotic in the treatment of Small Intestinal Bacterial Overgrowth (SIBO).
PEPTO-BISMOL STUDY
In conjunction with the Centers for Disease Control and Prevention (CDC) we are analyzing Pepto-Bismol in the Prevention of Travelers’ Diarrhea